Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387539 | SCV001588203 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-04-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr107Profs*48) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with HMG-CoA lyase deficiency (PMID: 28583327). ClinVar contains an entry for this variant (Variation ID: 1074299). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001387539 | SCV004199899 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-05-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001387539 | SCV005647153 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001831397 | SCV002094166 | pathogenic | Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency | 2021-02-01 | no assertion criteria provided | clinical testing |